2-Decarboxy-2-aminomethyl-9-deo
xy-6,9.alpha.-epoxymethano-5,6-didehydro-PGF.sub.1 compounds
    6.
    发明授权
    2-Decarboxy-2-aminomethyl-9-deo xy-6,9.alpha.-epoxymethano-5,6-didehydro-PGF.sub.1 compounds 失效
    2-脱羧基-2-氨基甲基-9-脱氧-6,9α-环氧甲烷-5,6-二脱氧-PGF1化合物

    公开(公告)号:US4234492A

    公开(公告)日:1980-11-18

    申请号:US67493

    申请日:1979-08-16

    申请人: Robert C. Kelly

    发明人: Robert C. Kelly

    摘要: The present invention relates to novel 2-decarboxy-2-aminomethyl-9-deoxy-6,9.alpha.-epoxymethano-5,6-didehydro-PGF.sub.1 compounds, which are useful for inducing a variety of prostacyclin-like pharmacological effects. Accordingly, these compounds are useful pharmacological agents for the same purposes for which prostacyclin is employed.

    摘要翻译: 本发明涉及可用于诱导各种前列环素样药理作用的新型2-脱羧基-2-氨基甲基-9-脱氧-6,9α-环氧甲烷-5,6-二脱氧-PGF1化合物。 因此,这些化合物是用于前列环素用于相同目的的有用的药理学试剂。

    Phenyl-substituted 9-deoxy-6,9.alpha.-epoxymethano-PG analogs
    7.
    发明授权
    Phenyl-substituted 9-deoxy-6,9.alpha.-epoxymethano-PG analogs 失效
    苯基取代的9-脱氧-6,9α-环氧甲烷 - PG类似物

    公开(公告)号:US4209615A

    公开(公告)日:1980-06-24

    申请号:US941510

    申请日:1978-09-11

    申请人: Robert C. Kelly

    发明人: Robert C. Kelly

    CPC分类号: C07C405/0041 C07D311/94

    摘要: Processes for preparing prostacyclin analogs which are 9-deoxy-6,9-epoxymethano derivatives of prostaglandin F.sub.1.alpha. -type compounds, illustrated, for example, by a compound of the formula ##STR1## wherein .about. indicates alpha or beta configuration; including the products and intermediates produced therein, said products having pharmacological utility.

    摘要翻译: 制备作为前列腺素F1α型化合物的9-脱氧-6,9-环氧甲烷衍生物的前列环素类似物的方法,例如由下式表示的化合物,其中DIFFERENCE表示α或β构型; 包括其中生产的产品和中间体,所述产品具有药理实用性。

    9-Deoxy-6,9.alpha.-epoxymethano-pg C-1 amides
    8.
    发明授权
    9-Deoxy-6,9.alpha.-epoxymethano-pg C-1 amides 失效
    9-脱氧-6,9α-环氧甲烷丙酰胺C-1酰胺

    公开(公告)号:US4208512A

    公开(公告)日:1980-06-17

    申请号:US941483

    申请日:1978-09-11

    申请人: Robert C. Kelly

    发明人: Robert C. Kelly

    CPC分类号: C07C405/0041 C07D311/94

    摘要: Processes for preparing prostacyclin analogs which are 9-deoxy-6,9-epoxymethano derivatives of prostaglandin F.sub.1.alpha. -type compounds, illustrated, for example, by a compound of the formula ##STR1## wherein .about.indicates alpha or beta configuration; including the products and intermediates produced therein, said products having pharmacological utility.

    摘要翻译: 制备作为前列腺素F1α型化合物的9-脱氧-6,9-环氧甲烷衍生物的前列环素类似物的方法,例如由下式表示的化合物,其中DIFFERENCE表示α或β构型; 包括其中生产的产品和中间体,所述产品具有药理实用性。

    9-Deoxy-6,9.alpha.-epoxymethano-PG C-1 amines
    9.
    发明授权
    9-Deoxy-6,9.alpha.-epoxymethano-PG C-1 amines 失效
    9-脱氧-6,9α-环氧甲烷-PG C-1胺

    公开(公告)号:US4204057A

    公开(公告)日:1980-05-20

    申请号:US941481

    申请日:1978-09-11

    申请人: Robert C. Kelly

    发明人: Robert C. Kelly

    CPC分类号: C07C405/0041 C07D311/94

    摘要: Processes for preparing prostacyclin analogs which are 9-deoxy-6,9-epoxymethano derivatives of prostaglandin F.sub.1.alpha. -type compounds, illustrated, for example, by a compound of the formula ##STR1## wherein .about. indicates alpha or beta configuration; including the products and intermediates produced therein, said products having pharmacological utility.

    摘要翻译: 制备作为前列腺素F1α型化合物的9-脱氧-6,9-环氧甲烷衍生物的前列环素类似物的方法,例如由下式表示的化合物,其中DIFFERENCE表示α或β构型; 包括其中生产的产品和中间体,所述产品具有药理实用性。

    Enlarged-hetero-ring prostacylin analogs
    10.
    发明授权
    Enlarged-hetero-ring prostacylin analogs 失效
    放大的杂环前列酰基类似物

    公开(公告)号:US4178441A

    公开(公告)日:1979-12-11

    申请号:US935296

    申请日:1978-08-21

    申请人: Robert C. Kelly

    发明人: Robert C. Kelly

    摘要: Prostaglandin (PG.sub.1) derivatives having (1) a 6-keto feature, together with a 9-deoxy-9-hydroxymethyl feature for example ##STR1## or (2) a 9-deoxy-6,9-epoxymethano feature together with a 5-halo or 6-hydroxy feature, for example ##STR2## or a 5,6-didehydro feature, for example in an enol ether of the formula. ##STR3## said derivatives having pharmacological activity. Processes for preparing them and the appropriate intermediates are disclosed.

    摘要翻译: 前体前列腺素(PG1)衍生物具有(1)6-酮特征,以及9-脱氧-9-羟甲基特征,例如(IMAGE)或(2)9-脱氧-6,9-环氧甲烷特征以及5 - 卤代或6-羟基特征,例如或+ TR 或5,6-Didehydro特征,例如在式的烯醇醚中。 所述衍生物具有药理活性。 公开了制备它们的方法和合适的中间体。